Pneumonia Testing Market: Global Industry Forecast (2022-2029) by Vehicle Type, Battery Type, Solar Panel, Charging Station, and Region

Pneumonia Testing Market size was valued at USD 1.73 Billion in 2021 and the total Pneumonia Testing Market revenue is expected to grow at 7.35% from 2022 to 2029, reaching nearly USD 3.10 Billion.

Pneumonia Testing Market Overview:

Pneumonia is a lung infection that inflames the air sacs in one or both lungs. The air sacs are filled with fluid or pus causing cough with pus or phlegm. Pneumonia ranges in seriousness from mild to life threatening. According to WHO Pneumonia accounts for 14% of all deaths of children and the annual incidence is approximately 151.7 million cases of which 8% to 12.5% require intensive treatment. Pneumonia affects children and families everywhere, but the deaths are highest in South Asia and sub-Saharan Africa. WHO and UNICEF has integrated Global Action Plan for Pneumonia and Diarrhea (GAPPD) and aims to accelerate pneumonia control with the combination of interventions to protect, prevent and treat Pneumonia, which has contributed to tremendous growth in Pneumonia Testing market. Various diagnosing tools are used while physical examination, review of medical history, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and fluid sample.

Research Scope:

The Pneumonia Testing Market report forecast the revenue growth at global regional and country levels and provides in depth analysis on the industry trends in each segments from 2017-2029.The market analysis focuses on various key aspects such as key industry, market dynamics, mergers and acquisition and partnership, technological advancements, regulatory and reimbursement scenario ,major key players Apart from this the market report includes in depth insights of the market trends and highlights the key industry dynamics .In addition to this the report also includes numerous factors and market statistics which has contributed to the growth of the market in the recent years. The study displays the results of the PORTER and PESTEL analyses as well as probable outcomes of the microeconomic market elements. After accounting for internal and external variables that can have a favourable or unfavourable impact on the firm, decision-makers will have a clear futuristic perspective of the market. Pneumonia Testing MarketTo know about the Research Methodology:-Request Free Sample Report

Pneumonia Testing Market Dynamics:

Market Drivers: Significant increase in the prevalence of pneumonia is one of the major factors to propel the global market growth .pediatric and old–aged pneumonia population have an increased susceptibility in developing Pneumonia, for Instance, according to WHO and UNICEF reports Pneumonia kills more children than any other infectious disease claiming the lives of over 7,00,000 children under five every year or around 2,000 everyday .Globally there are over 1,400 cases of Pneumonia per 1,00,000 children or 1 case per 71 children every year with the greatest incidence occurring in South Asia and west and Central Africa .These aforementioned factors are significantly contributing towards the growth of Global Pneumonia testing market. Point of care (POC) testing and advancements in the nucleic acid detection sector on a global scale are the major factors propelling the growth of the global market for pneumonia testing. The rise in the elderly population, the explosion in diagnostic advancements for pneumonia, and the incidence of pneumonia in children around the world all contribute to the market's expansion. Additionally, Pneumonia Testing Market Opportunity, the presence of a sophisticated healthcare infrastructure, the availability of reimbursements, and the existence of significant market participants are contributing towards the growth of Pneumonia Testing Market. Market Opportunities: Furthermore, it is projected that a steady rise in financing opportunities for research to produce new goods are contributing towards the potential growth during the forecasted years. For instance, the Bill & Melinda Gates Foundation is one of the financing organizations that supports the creation of novel vaccinations and attempts to solve the issue of newborn pneumococcal disease. Research funding is also encouraged by the emergence of resistant strains and the resulting rise in demand for novel antibiotics. The Biomedical Advanced Research and Development Authority provided an initial funding of USD 32 million to The Medicines Company, and it will provide an additional USD 100 million over the course of five years in order to develop a portfolio of next-generation antibiotics that are anticipated to aid in the fight against drug-resistant infections.

Pneumonia Testing Market Segment Analysis:

Based on Product Type, Analyser segment dominate the global pneumonia testing market, which it held more than two-thirds of in 2021. The rise of this market sector is being driven by an increase in pneumonia prevalence worldwide. On the other hand, due to the widespread usage of pneumonia tests, the consumables section is anticipated to increase at the fastest rate, or 7.0 percent, throughout the projected period. Based on End-User, Diagnostic Laboratories dominate the world market for Pneumonia testing market. The diagnostic laboratories, which has innovative technology, and additionally, maintaining their equipment and hiring highly skilled personnel costs a lot of money for diagnostic laboratories. Patients have instant access to hospitals' in-house labs for testing and diagnosis, which contributes in reducing the need for patients to travel between pathology labs. Furthermore rising awareness and demand for the pneumonia diagnosis plays crucial reasons for growth of the clinic and hospital segment. Pneumonia Testing Market Based on Type, the global market is segmented into legionella-based, streptococcus-based, viral pneumonia based, mycoplasma based .The streptococcus based segment held a dominant pneumonia testing market share in the year 2021.The viral based pneumonia-based segment is anticipated to hold second leading position during the forecast period. The legionella based segment held a substantial market share in 2021 due to the rising cases and adaptation of point of care diagnostic kits.The mycoplasma pneumonia and chlamydophila based segments are estimated to grow at a low CAGR as there are less common causes of pneumonia. Pneumonia Testing Market

Pneumonia Testing Market Regional Insights:

North America's market, which had a 2021 value of USD 222.5 million, is anticipated to hold a significant portion of the global market over the projection period. Due to its high rate of pneumonia cases, quick uptake of point-of-care devices, and kind reimbursement practices, North America controls the majority of the global market. Additionally, the launch of technologically advanced products and the presence of key companies in the U.S. are some of the factors promoting the expansion of regional markets like North America. The European market is anticipated to be the second-largest due to increase in hospital admissions as well as crucial government campaigns to boost public knowledge of pneumonia testing. For instance, pneumonia is the second most common cause of in-hospital fatalities in Europe, according to a study that was published by BMC in January 2021, and respiratory disorders account for 15.5 % of these deaths. Also, pneumonia accounts for 2.5% of the 7.2% of hospital admissions. As a result, the European market will probably benefit from the growing patient pool.

Pneumonia Testing Market Scope: Inquire before buying

Pneumonia Testing Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2029
Historical Data: 2017 to 2021 Market Size in 2021: US $ 1.73 Bn.
Forecast Period 2022 to 2029 CAGR: 7.75% Market Size in 2029: US $ 3.10 Bn.
Segments Covered: by Product Type • Analyzer segment • Consumable segment
by End-User • Diagnostic Laboratories • Hospitals • Clinics • Others
by Type • legionella-based • streptococcus-based • viral pneumonia based • mycoplasma based

Pneumonia Testing Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Pneumonia Testing Market Key Players

• Thermo Fisher Scientific Inc. • Abbott Laboratories • F-Hoffmann la Roche Ltd. • Hologic Inc. • BioMerieux • Becton • Dickenson and Company • Bio-Rad Laboratories Inc. • Meridian Biosciences • Quest Diagnostics, and Quidel. • AdvanDx • Beckman Coulter • Cepheid • Concile • Diamedix • DiaSorin • Fast-track Diagnostics • SeraCare • Trinity Biotech FAQs: 1. Which is the potential market for the Pneumonia Testing Market in terms of the region? Ans. In North America region, the growing business and are expected to help drive the use of collaborative screens. 2. What are the opportunities for new market entrants? Ans. The key opportunity in the market is new initiatives from governments that provide funding for Pneumonia Testing Markets in healthcare industries. 3. What is expected to drive the growth of the Pneumonia Testing Market in the forecast period? Ans. A major driver in the Pneumonia Testing Market is the prevalence of cold-cough related diseases during COVID-19 pandemic 4. What is the projected market size & growth rate of the Pneumonia Testing Market? Ans. The Pneumonia Testing Market size was valued at US$ 1.73 Billion in 2021 and the total Pneumonia Testing Market revenue is expected to grow at 7.35 % through 2021 to 2029, reaching nearly US$ 3.10 Billion. 5. What segments are covered in the Pneumonia Testing Market report? Ans. The segments covered are by product type, End-user, by bacterial type, by Region.
1. Global Pneumonia Testing Market: Research Methodology 2. Global Pneumonia Testing Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Pneumonia Testing Market 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Pneumonia Testing Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • South America 3.12 COVID-19 Impact 4. Global Pneumonia Testing Market Segmentation 4.1 Global Pneumonia Testing Market, by Product Type (2021-2029) • Analyzer segment • Consumable segment 4.2 Global Pneumonia Testing Market, by End-User (2021-2029) • Diagnostic Laboratories • Hospitals • Clinics • Others 4.3 Global Pneumonia Testing Market, by Type (2021-2029) • legionella-based • streptococcus-based • viral pneumonia based • mycoplasma based 5. North America Pneumonia Testing Market (2021-2029) 5.1 North America Pneumonia Testing Market, by Product Type (2021-2029) • Analyzer segment • Consumable segment 5.2 North America Pneumonia Testing Market, by End-User (2021-2029) • Diagnostic Laboratories • Hospitals • Clinics • Others 5.3 North America Pneumonia Testing Market, by Type (2021-2029) • legionella-based • streptococcus-based • viral pneumonia based • mycoplasma based 5.4 North America Pneumonia Testing Market, by Country (2021-2029) • United States • Canada • Mexico 6. Europe Pneumonia Testing Market (2021-2029) 6.1. European Pneumonia Testing Market, by Product Type (2021-2029) 6.2. European Pneumonia Testing Market, by End-User (2021-2029) 6.3. European Pneumonia Testing Market, by Type (2021-2029) 6.4. European Pneumonia Testing Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Pneumonia Testing Market (2021-2029) 7.1. Asia Pacific Pneumonia Testing Market, by Product Type (2021-2029) 7.2. Asia Pacific Pneumonia Testing Market, by End-User (2021-2029) 7.3. Asia Pacific Pneumonia Testing Market, by Type (2021-2029) 7.4. Asia Pacific Pneumonia Testing Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Pneumonia Testing Market (2021-2029) 8.1 Middle East and Africa Pneumonia Testing Market, by Product Type (2021-2029) 8.2. Middle East and Africa Pneumonia Testing Market, by End-User (2021-2029) 8.3. Middle East and Africa Pneumonia Testing Market, by Type (2021-2029) 8.4. Middle East and Africa Pneumonia Testing Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Pneumonia Testing Market (2021-2029) 9.1. South America Pneumonia Testing Market, by Product Type (2021-2029) 9.2. South America Pneumonia Testing Market, by End-User (2021-2029) 9.3. South America Pneumonia Testing Market, by Type (2021-2029) 9.4. South America Pneumonia Testing Market, by Country (2021-2029) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1 Thermo Fisher Scientific Inc. 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2 Abbott Laboratories 10.3 F-Hoffmann la Roche Ltd. 10.4 Hologic Inc. 10.5 BioMerieux 10.6 Becton 10.7 Dickenson and Company 10.8 Bio-Rad Laboratories Inc. 10.9 Meridian Biosciences 10.10 Quest Diagnostics, and Quidel. 10.11 AdvanDx 10.12 Beckman Coulter 10.13 Cepheid 10.14 Concile 10.15 Diamedix 10.16 DiaSorin 10.17 Fast-track Diagnostics 10.18 SeraCare 10.19 Trinity Biotech

About This Report

Report ID 112576
Category Healthcare
Published Date Sept 2022
Updated Date
Contact Us